Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03983668
Title CMP-001 for Relapsed and Refractory Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Umar Farooq

non-Hodgkin lymphoma

Hodgkin's lymphoma


Pembrolizumab + Vidutolimod

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.